Brighton Jones’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$442K Buy
7,578
+125
+2% +$7.37K 0.01% 861
2026
Q2
$418K Buy
7,453
+1,368
+22% +$71.2K 0.01% 881
2026
Q1
$292K Buy
+6,085
New +$267K 0.01% 946

Other funds holding RPRX

Brighton Jones's RPRX Position: Q3 2026 in Review

Brighton Jones increased its Royalty Pharma (RPRX) stake by 1.7% in Q3 2026, buying an estimated $7.37K and bringing the position to 7,578 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #861.

Brighton Jones first reported a position in RPRX in Q1 2026 and has held it in 3 quarters since. 585 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Brighton Jones held 7,578 shares of Royalty Pharma worth $442K as of Q3 2026.
  • Brighton Jones bought 125 Royalty Pharma shares in Q3 2026, an estimated $7.37K.
  • Royalty Pharma made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #861 holding.
  • Brighton Jones first reported a position in Royalty Pharma in Q1 2026 and has held it in 3 quarters since.
  • 585 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.